Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2020-04-21
- Target Recruit Count
- 70
- Registration Number
- NCT04070807
- Locations
- 🇮🇹
ASST Cremona, Cremona, CR, Italy
🇮🇹A.O. Pugliese Ciaccio, Catanzaro, CZ, Italy
🇮🇹Irst Irccs, Meldola, FC, Italy
Emilia-Romagna Surgical Colorectal Cancer Audit- ESCA
- Conditions
- Colorectal CancerFinancial BenefitAuditing ActivitySurgery
- First Posted Date
- 2019-06-11
- Last Posted Date
- 2019-06-11
- Target Recruit Count
- 1400
- Registration Number
- NCT03982641
- Locations
- 🇮🇹
Istituto Scientifico Romagnolo per lo studio e la cura dei tumori, Meldola, FC, Italy
🇮🇹AUO Chirurgia Generale e D'Urgenza Ospedale M.Bufalini, Cesena, Forli-Cesena, Italy
🇮🇹AUO CHIRURGIA GENERALE OSPEDALE G. B. Morgagni- Pierantoni, Forlì, Forli-Cesena, Italy
ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate
- Conditions
- Acute Lymphoblastic Leukemia
- First Posted Date
- 2019-04-01
- Last Posted Date
- 2021-02-26
- Target Recruit Count
- 120
- Registration Number
- NCT03898128
- Locations
- 🇮🇹
Irst Irccs, Meldola (FC), FC, Italy
🇮🇹AUSL Romagna, Ravenna, RA, Italy
🇮🇹Azienda ULSS2 Marca Trevigiana, Treviso, TV, Italy
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2018-12-31
- Last Posted Date
- 2021-02-26
- Target Recruit Count
- 75
- Registration Number
- NCT03789981
- Locations
- 🇮🇹
AO Spedali Civili di Brescia, Brescia, BS, Italy
🇮🇹Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy
🇮🇹IRCCS Casa sollievo sofferenza, San Giovanni Rotondo, Foggia, Italy
Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy
- Conditions
- Radiotherapy; ComplicationsTomotherapyProstate Adenocarcinoma
- First Posted Date
- 2018-06-12
- Last Posted Date
- 2023-05-30
- Target Recruit Count
- 2
- Registration Number
- NCT03553212
- Locations
- 🇮🇹
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies
- Conditions
- Mesothelioma, MalignantPD-L1 NegativeAdvanced CancerProgressive Disease
- Interventions
- First Posted Date
- 2018-06-06
- Last Posted Date
- 2024-10-01
- Target Recruit Count
- 18
- Registration Number
- NCT03546426
- Locations
- 🇮🇹
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy
Italian Non-Interventional Study of FLT3 Mutated AML Patients
- Conditions
- AMLFLT3-TKD MutationFLT3-ITD Mutation
- First Posted Date
- 2018-06-06
- Last Posted Date
- 2020-04-21
- Target Recruit Count
- 800
- Registration Number
- NCT03547258
- Locations
- 🇮🇹
AOU Ospedali riuniti di Ancona, Ancona, AN, Italy
🇮🇹AOU Policlinico Bari - Ematologia, Bari, BA, Italy
🇮🇹Università di Bologna - DIMES, Bologna, BO, Italy
Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.
- Conditions
- Diagnosis68Ga-PSMA PET/CT Guided Prostate BiopsyMp-3TMRI Guided Prostate BiopsyTNM StagingProstate Cancer
- First Posted Date
- 2018-03-14
- Last Posted Date
- 2025-01-30
- Target Recruit Count
- 261
- Registration Number
- NCT03465579
- Locations
- 🇮🇹
AUSL della Romagna, Forlì, FC, Italy
🇮🇹Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy
Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)
- Conditions
- Metastatic Castration Resistant Prostate Cancer68Ga-PSMA PET/CT Positive
- Interventions
- First Posted Date
- 2018-03-06
- Last Posted Date
- 2025-01-08
- Target Recruit Count
- 143
- Registration Number
- NCT03454750
- Locations
- 🇮🇹
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy
Optimizing the Interval Between Cycles of PRRT With 177lu-dotatate in sstr2 Positive Tumors
- Conditions
- Neuroendocrine Tumors
- Interventions
- Drug: PRRT every 5 weeksDrug: PRRT every 8-10 weeks
- First Posted Date
- 2018-03-06
- Last Posted Date
- 2020-04-21
- Target Recruit Count
- 618
- Registration Number
- NCT03454763
- Locations
- 🇮🇹
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy